The results of a meta-analysis of two phase III studies, announced here during Digestive Disease Week 2008, show that the investigational proton pump inhibitor TAK-390mr (TAP Pharmaceutical Products, Inc., Lake Forest, Illinois) achieves better healing rates and maintains longer pH control than lansoprazole (Prevacid, TAP Pharmaceutical Products, Inc.). Reuters Health Information
Five years after undergoing primary laparoscopic fundoplication for gastroesophageal reflux disease (GERD), patients report near-normal health-related quality of life (HRQL) and are satisfied with their treatment decision, new research indicates. Reuters Health Information
Colorectal lesions with malignant potential can be differentiated from non-neoplastic polyps during colonoscopy, investigators announced here during Digestive Disease Week 2008. Reuters Health Information
The effectiveness of PEG-IFN/RBV therapy and factors predicting SVR in everyday clinical practice mirror those reported in randomized-controlled studies. Alimentary Pharmacology & Therapeutics
Gastrointestinal stromal tumor metastases can be controlled by imatinib but not by systemic chemotherapy/radiotherapy. Can imatinib be used as adjuvant therapy in GIST patients at risk for metastases? Nature Clinical Practice Oncology
In a study at Stanford University, patients who took probiotics after Roux en Y gastric bypass surgery (RNYGB) lost more weight than RNYGB patients who did not. Reuters Health Information
IV cyclosporine is an effective therapy for patients with IBD; however, data regarding its adverse events in these patients are limited. The American Journal of Gastroenterology
